Olema Pharmaceuticals, Inc. (OLMA) Tops Q2 EPS by 24c

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) reported Q2 EPS of ($0.49), $0.24 better than the analyst estimate of ($0.73).

For earnings history and earnings-related data on Olema Pharmaceuticals, Inc. (OLMA) click here.

You May Also Be Interested In

• Olema Pharmaceuticals (OLMA) PT Lowered to $36 at H.C. Wainwright
• McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
• Pyxis Oncology, Inc. (PYXS) Misses Q2 EPS by 4c